Gen-Probe Adds European Reach Through $132 Million Tepnel Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe will double its European sales force and expand its existing molecular diagnostics portfolio through the $132.2 million purchase of UK-based Tepnel Life Sciences